resorcinol has been researched along with Acne Inversa in 7 studies
resorcinol: RN given refers to parent cpd; structure in Merck Index, 9th ed, #7951
resorcinol : A benzenediol that is benzene dihydroxylated at positions 1 and 3.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Topical resorcinol 15% is a self-treatment for painful hidradenitis suppurativa nodules and abscesses with good results in reducing pain and lesion duration." | 8.12 | Formulation, long-term physicochemical and microbiological stability of 15% topical resorcinol for hidradenitis suppurativa. ( Barros-Tornay, R; Calleja-Hernández, MÁ; Cameán-Fenández, M; Cordero-Ramos, J; Delgado-Valverde, M; Merino-Bohórquez, V, 2022) |
| "Topical treatment with 15% resorcinol reduced pain from painful nodules in all patients with HS." | 7.76 | Resorcinol peels as a possible self-treatment of painful nodules in hidradenitis suppurativa. ( Boer, J; Jemec, GB, 2010) |
| "Topical resorcinol 15% is a self-treatment for painful hidradenitis suppurativa nodules and abscesses with good results in reducing pain and lesion duration." | 4.12 | Formulation, long-term physicochemical and microbiological stability of 15% topical resorcinol for hidradenitis suppurativa. ( Barros-Tornay, R; Calleja-Hernández, MÁ; Cameán-Fenández, M; Cordero-Ramos, J; Delgado-Valverde, M; Merino-Bohórquez, V, 2022) |
| "Topical treatment with 15% resorcinol reduced pain from painful nodules in all patients with HS." | 3.76 | Resorcinol peels as a possible self-treatment of painful nodules in hidradenitis suppurativa. ( Boer, J; Jemec, GB, 2010) |
| "Hidradenitis suppurativa is a chronic, recurrent, and debilitating skin condition." | 2.55 | What is hidradenitis suppurativa? ( Alhusayen, R; Lansang, P; Lee, EY; Shear, N; Yeung, J, 2017) |
| "The diagnosis of eruptive xanthoma (EX) was clinically confirmed." | 1.56 | Concomitant Hidradenitis Suppurativa and Eruptive Xanthomas Presenting with Phimosis - The Importance of Timely Diagnosis. ( Andersen, RK; Ernst Jemec, GB; Saunte, DM; Yazdanyar, S, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 3 (42.86) | 2.80 |
| Authors | Studies |
|---|---|
| Riis, PT | 1 |
| Saunte, DM | 2 |
| Sigsgaard, V | 1 |
| Villani, AP | 1 |
| Guillem, P | 1 |
| Pascual, JC | 2 |
| Kappe, NN | 1 |
| Vanlaerhoven, AMJD | 1 |
| van der Zee, HH | 1 |
| Prens, EP | 1 |
| El-Domyati, M | 1 |
| Abdel-Wahab, H | 1 |
| Moftah, N | 1 |
| Abdelghani, R | 1 |
| Agut-Busquet, E | 1 |
| Romaní, J | 1 |
| Hlela, C | 1 |
| van den Worm, L | 1 |
| Bettoli, V | 1 |
| Calamo, G | 1 |
| Gürer, MA | 1 |
| Beksaç, B | 1 |
| Matusiak, L | 1 |
| Glowaczewska, A | 1 |
| Szepietowski, JC | 1 |
| Emtestam, L | 1 |
| Lapins, J | 1 |
| Kottb, HR | 1 |
| Fatani, M | 1 |
| Weibel, L | 1 |
| Theiler, M | 1 |
| Delage-Toriel, M | 1 |
| Lam, TTH | 1 |
| Nassif, A | 1 |
| Becherel, PA | 1 |
| Dolenc-Voljc, M | 1 |
| Doss, N | 1 |
| Bouazzi, D | 1 |
| Benhadou, F | 1 |
| Del Marmol, V | 1 |
| Jemec, GBE | 1 |
| Cordero-Ramos, J | 1 |
| Merino-Bohórquez, V | 1 |
| Delgado-Valverde, M | 1 |
| Barros-Tornay, R | 1 |
| Cameán-Fenández, M | 1 |
| Calleja-Hernández, MÁ | 1 |
| Andersen, RK | 1 |
| Yazdanyar, S | 1 |
| Ernst Jemec, GB | 1 |
| Encabo, B | 1 |
| Ruiz de Apodaca, RF | 1 |
| Romero, D | 1 |
| Selva, J | 1 |
| Jemec, GB | 2 |
| Alavi, A | 1 |
| Kirsner, RS | 1 |
| Lee, EY | 1 |
| Alhusayen, R | 1 |
| Lansang, P | 1 |
| Shear, N | 1 |
| Yeung, J | 1 |
| Boer, J | 1 |
2 reviews available for resorcinol and Acne Inversa
| Article | Year |
|---|---|
Local wound care and topical management of hidradenitis suppurativa.
Topics: Administration, Cutaneous; Adult; Anti-Infective Agents, Local; Clindamycin; Combined Modality Thera | 2015 |
What is hidradenitis suppurativa?
Topics: Anti-Bacterial Agents; Biological Products; Hidradenitis Suppurativa; Hormones; Humans; Immunosuppre | 2017 |
1 trial available for resorcinol and Acne Inversa
| Article | Year |
|---|---|
Topical 15% resorcinol for hidradenitis suppurativa: An uncontrolled prospective trial with clinical and ultrasonographic follow-up.
Topics: Administration, Topical; Adolescent; Adult; Aged; Female; Follow-Up Studies; Hidradenitis Suppurativ | 2017 |
4 other studies available for resorcinol and Acne Inversa
| Article | Year |
|---|---|
Clinical characteristics of pediatric hidradenitis suppurativa: a cross-sectional multicenter study of 140 patients.
Topics: Acne Vulgaris; Administration, Cutaneous; Administration, Oral; Adolescent; Anti-Bacterial Agents; B | 2020 |
Formulation, long-term physicochemical and microbiological stability of 15% topical resorcinol for hidradenitis suppurativa.
Topics: Aluminum; Amber; Chemical Phenomena; Drug Stability; Emulsions; Hidradenitis Suppurativa; Humans; Pa | 2022 |
Concomitant Hidradenitis Suppurativa and Eruptive Xanthomas Presenting with Phimosis - The Importance of Timely Diagnosis.
Topics: Delayed Diagnosis; Diagnosis, Differential; Drug Therapy, Combination; Glucocorticoids; Hidradenitis | 2020 |
Resorcinol peels as a possible self-treatment of painful nodules in hidradenitis suppurativa.
Topics: Adult; Drug Administration Schedule; Female; Hidradenitis Suppurativa; Humans; Middle Aged; Pain; Pa | 2010 |